Connecticut Seal

General Assembly

 

Substitute Bill No. 5912

    January Session, 2005

*_____HB05912CE_JUD031105____*

AN ACT PROMOTING STEM CELL RESEARCH IN THE STATE.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective July 1, 2005) (a) There is established a Connecticut Advanced Cell Advisory Council. Said council shall consist of the chairperson of Connecticut Innovations, Incorporated, or said chairperson's designee, and twelve members appointed as follows: Four by the Governor, two by the president pro tempore of the Senate, two by the speaker of the House of Representatives, one by the majority leader of the Senate, one by the majority leader of the House of Representatives, one by the minority leader of the Senate and one by the minority leader of the House of Representatives. Ten of such appointed members shall (1) possess knowledge, skill and expertise in the field of embryonic, adult and umbilical cord stem cell research, (2) be working as researchers or scientists or in other capacities, for academic institutions, industry, nonprofit organizations or government to advance embryonic, adult and umbilical cord stem cell research in the state, and (3) have favorable reputations for such knowledge, skill, expertise and experience. Two of such appointed members shall be experienced in the field of commerce, trade and business. All appointments to the committee shall be made by November 1, 2005. Each appointed member shall serve for a term of four years. Any vacancy on the council shall be filled by the appointing authority.

(b) The chairperson of Connecticut Innovations, Incorporated, or the chairperson's designee, shall serve as the chairperson of the council and shall schedule the first meeting of the council, which shall be held not later than December 1, 2005.

(c) Not later than June 30, 2006, and annually thereafter, the Connecticut Advanced Cell Advisory Council shall submit a report to the joint standing committees of the General Assembly having cognizance of matters relating to commerce and public health, in accordance with the provisions of section 11-4a of the general statutes. Said report shall (1) include an analysis of the status of embryonic, adult and umbilical cord stem cell research in the state, and (2) examine and identify specific ways to improve and promote for profit and not-for-profit embryonic, adult and umbilical cord stem cell research in the state, including, but not limited to, identifying both public and private funding sources for such research, maintaining existing embryonic, adult and umbilical cord stem cell related businesses, recruiting new embryonic, adult and umbilical cord stem cell related businesses to the state and recruiting scientists and researchers in such field to the state.

Sec. 2. (NEW) (Effective July 1, 2005) (a) There is established the "Stem Cell Research Fund", which shall be a separate, nonlapsing fund managed by Connecticut Innovations, Incorporated. The fund may contain any moneys required by law to be deposited in the fund and any funds received from any public or private contributions, gifts, grants, donations, bequests or devises. Investment earnings credited to the assets of the fund shall become part of the assets of the fund. The moneys in the fund shall be used by Connecticut Innovations, Incorporated to advance embryonic, adult and umbilical cord stem cell research in Connecticut pursuant to subsection (b) of this section. Any balance remaining in the account at the end of any fiscal year shall be carried forward in the account for the next fiscal year.

(b) Connecticut Innovations, Incorporated shall use the moneys in the Stem Cell Research Fund, on the recommendation of the Connecticut Advanced Cell Advisory Council, to (1) develop a program to encourage the donation of funds to supplement state appropriations to the Stem Cell Research Fund, (2) establish and administer a stem cell research grant program under which grants shall be provided to research institutions for the advancement of embryonic, adult and umbilical cord stem cell and related research, (3) establish a separate peer review committee that shall review grants under said program, (4) establish and administer a stem cell research facilities fund for the construction of laboratory and related space, and (5) establish and administer a program for the purpose of investing in embryonic, adult and umbilical cord stem cell related businesses. The Commissioner of Public Health, or said commissioner's designee, shall be an ex-officio member of the peer review committee established under subdivision (3) of this subsection. Connecticut Innovations, Incorporated, shall carry out the provisions of this subsection in conjunction with other state, quasi-public agency and federal programs. The board of directors of Connecticut Innovations, Incorporated shall adopt written procedures, in accordance with the provisions of section 1-121 of the general statutes, for the allocation and expenditure of moneys under this section.

Sec. 3. (Effective July 1, 2005) The sum of ten million dollars is appropriated to the Stem Cell Research Fund established pursuant to section 2 of this act, from the General Fund, for each fiscal year, from the fiscal year ending June 30, 2006, until the fiscal year ending June 30, 2015, inclusive.

This act shall take effect as follows and shall amend the following sections:

Section 1

July 1, 2005

New section

Sec. 2

July 1, 2005

New section

Sec. 3

July 1, 2005

New section

CE

Joint Favorable Subst. C/R

JUD